The story has been updated to include comments from a conference call this morning.

NEW YORK (GenomeWeb News) – GenMark Diagnostic's third-quarter revenues increased four-fold year over year, the Carlsbad, Calif.-based molecular diagnostics firm reported after the close of the market on Wednesday.

For the three months ended Sept. 30, revenues rose to $5.3 million from $1.3 million, with product revenues reaching $5.2 million, compared to $1.2 million a year ago. Licensing and other revenues fell to $62,000 from $110,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.